Guardant Health Inc. (GH) stock soared 5.08% in early trading on Wednesday, following a strong quarterly performance that prompted Piper Sandler to raise its price target on the company.
According to the news, Piper Sandler analyst David Westenberg raised the firm's price target on Guardant Health to $50 from $34, reflecting the company's solid financial results and positive outlook.
The stock price surge indicates investors' confidence in Guardant Health's prospects, as the company continues to innovate and expand its offerings in the healthcare sector.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。